Hongjuan Dai
- Bioengineering top 10%
-
- Bone Tissue Engineering Materials 2
-
- RNA Interference and Gene Delivery 3
- Advanced biosensing and bioanalysis techniques 2
-
- Multiple Myeloma Research and Treatments 2
-
- Pancreatic and Hepatic Oncology Research 2
- Cancer-related Molecular Pathways 2
-
- Pancreatic function and diabetes 2
-
- Analytical chemistry methods development 1
- Journals
- Applied Surface Science (1 paper)Acta Biomaterialia (1 paper)Cancer Cell International (1 paper)
- Partner nations
- ChinaBangladesh
In The Last Decade
Hongjuan Dai
13 papers receiving 348 citations
Peers
Comparison fields: 5 of 78
- Bioengineering 35
- Pharmacology 41
- Biomedical Engineering 101
- Orthodontics 10
- Biomaterials 28
Countries citing papers authored by Hongjuan Dai
This map shows the geographic impact of Hongjuan Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongjuan Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongjuan Dai more than expected).
Fields of papers citing papers by Hongjuan Dai
This network shows the impact of papers produced by Hongjuan Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongjuan Dai. The network helps show where Hongjuan Dai may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hongjuan Dai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 3 | |
| 2 | 2021 | 5 | |
| 3 | 2021 | 9 | |
| 4 | 2020 | 32 | |
| 5 | 2019 | 9 | |
| 6 | Targeting β2 subunit of Na+/K+-ATPase induces glioblastoma cell apoptosis through elevation of intracellular Ca2. | 2019 | 18 |
| 7 | 2018 | 52 | |
| 8 | 2014 | 6 | |
| 9 | 2013 | 1 | |
| 10 | 2012 | 79 | |
| 11 | 2008 | 14 | |
| 12 | 2007 | 66 | |
| 13 | 2007 | 66 |
About Hongjuan Dai
Hongjuan Dai is a scholar working on Hematology, Bioengineering and Electrochemistry, having authored 13 papers that have together received 360 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (3 papers), Bone Tissue Engineering Materials (2 papers), Multiple Myeloma Research and Treatments (2 papers), Advanced biosensing and bioanalysis techniques (2 papers), Pancreatic and Hepatic Oncology Research (2 papers), Cancer-related Molecular Pathways (2 papers), Pancreatic function and diabetes (2 papers) and Analytical chemistry methods development (1 paper). The work is most often cited by research in Bioengineering (35 citations), Pharmacology (41 citations) and Biomedical Engineering (101 citations). Hongjuan Dai has collaborated with scholars based in China and Bangladesh. Frequent co-authors include Shihui Si, Zhengpeng Yang, Chunjing Zhang, Bin Sun, Xudong Zhao, Jie Zheng, Huiyong Chen, Lu Li, Mao Ye and Jing Liu. Their work appears in journals such as Applied Surface Science, Acta Biomaterialia, Cancer Cell International, Journal of Biomedical Nanotechnology and Disease Models & Mechanisms.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.